James R. Meyers has been promoted to executive vice president, Worldwide Commercial Operations at Gilead Sciences. Mr. Meyers will be responsible for commercial operations in North America, Europe and Japan. He will become an officer of the company and member of the senior leadership team.

Mr. Meyers joined the company in 1996 as a regional sales director and has served as senior vice president of North American Commercial Operations since 2007. In his 20 years at Gilead, Mr. Meyers has been instrumental in building out the company’s commercial operations in North America, including leading successful product launches in HIV, oncology, cardiovascular, respiratory and liver diseases.

“Jim has demonstrated a remarkable ability to navigate the complexities of commercial operations, ensuring we reach diverse audiences with information about Gilead’s medicines and ultimately that we make those medicines accessible to people in need,” said Kevin Young CBE, Chief Operating Officer, Gilead Sciences. “I am confident that as Gilead’s portfolio of products continues to grow, Jim’s leadership and exceptional track record make him ideally suited to lead our global commercial organization.”